KR100460361B1 - 요중단백질검출용시험스트립및요중단백질시험 - Google Patents
요중단백질검출용시험스트립및요중단백질시험 Download PDFInfo
- Publication number
- KR100460361B1 KR100460361B1 KR1019960048173A KR19960048173A KR100460361B1 KR 100460361 B1 KR100460361 B1 KR 100460361B1 KR 1019960048173 A KR1019960048173 A KR 1019960048173A KR 19960048173 A KR19960048173 A KR 19960048173A KR 100460361 B1 KR100460361 B1 KR 100460361B1
- Authority
- KR
- South Korea
- Prior art keywords
- tartaric acid
- protein
- buffer
- strip
- cationic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 75
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 75
- 210000002700 urine Anatomy 0.000 title claims abstract description 36
- 238000012360 testing method Methods 0.000 title claims abstract description 30
- 238000002331 protein detection Methods 0.000 title description 3
- 239000000872 buffer Substances 0.000 claims abstract description 69
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 46
- 239000011975 tartaric acid Substances 0.000 claims abstract description 46
- 235000002906 tartaric acid Nutrition 0.000 claims abstract description 46
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000007853 buffer solution Substances 0.000 claims abstract description 4
- 125000002091 cationic group Chemical group 0.000 claims description 26
- 239000000975 dye Substances 0.000 claims description 24
- 239000006172 buffering agent Substances 0.000 claims description 22
- 230000008859 change Effects 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 15
- 239000002250 absorbent Substances 0.000 claims description 13
- 230000002745 absorbent Effects 0.000 claims description 13
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical group C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 claims description 5
- 230000035945 sensitivity Effects 0.000 claims description 4
- 230000000630 rising effect Effects 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- QPMIVFWZGPTDPN-UHFFFAOYSA-N Tetrabromophenol blue Chemical group C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C(C(Br)=C(Br)C(Br)=C2Br)=C2S(=O)(=O)O1 QPMIVFWZGPTDPN-UHFFFAOYSA-N 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 150000001768 cations Chemical class 0.000 abstract description 35
- 230000003139 buffering effect Effects 0.000 abstract description 18
- 239000000463 material Substances 0.000 abstract description 6
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 36
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 238000001514 detection method Methods 0.000 description 15
- 238000009835 boiling Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- NMHYCKTXIQQVPE-UHFFFAOYSA-N 2-iodo-6-nitro-4-[4,5,6,7-tetrabromo-3-(4-hydroxy-3-iodo-5-nitrophenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]phenol Chemical compound Oc1c(I)cc(cc1[N+]([O-])=O)C1(OS(=O)(=O)c2c1c(Br)c(Br)c(Br)c2Br)c1cc(I)c(O)c(c1)[N+]([O-])=O NMHYCKTXIQQVPE-UHFFFAOYSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 5
- 125000002843 carboxylic acid group Chemical group 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 230000002485 urinary effect Effects 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229960003975 potassium Drugs 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229940095064 tartrate Drugs 0.000 description 3
- CWPKTBMRVATCBL-UHFFFAOYSA-N 3-[1-[1-[(2-methylphenyl)methyl]piperidin-4-yl]piperidin-4-yl]-1h-benzimidazol-2-one Chemical compound CC1=CC=CC=C1CN1CCC(N2CCC(CC2)N2C(NC3=CC=CC=C32)=O)CC1 CWPKTBMRVATCBL-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- -1 cationic cation Chemical class 0.000 description 2
- 150000001860 citric acid derivatives Chemical class 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 229960002635 potassium citrate Drugs 0.000 description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- KUQNCHZOCSYKOR-UHFFFAOYSA-N 1,1-dioxospiro[2,1$l^{6}-benzoxathiole-3,9'-xanthene]-3',4',5',6'-tetrol Chemical compound O1S(=O)(=O)C2=CC=CC=C2C21C1=CC=C(O)C(O)=C1OC1=C(O)C(O)=CC=C21 KUQNCHZOCSYKOR-UHFFFAOYSA-N 0.000 description 1
- BSWWXRFVMJHFBN-UHFFFAOYSA-N 2,4,6-tribromophenol Chemical compound OC1=C(Br)C=C(Br)C=C1Br BSWWXRFVMJHFBN-UHFFFAOYSA-N 0.000 description 1
- HGPSVOAVAYJEIJ-XDHOZWIPSA-N 2-[(e)-(3,4-dihydroxyphenyl)-(3-hydroxy-4-oxoniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzenesulfonate Chemical compound C1=CC(=O)C(O)=C\C1=C(C=1C(=CC=CC=1)S(O)(=O)=O)/C1=CC=C(O)C(O)=C1 HGPSVOAVAYJEIJ-XDHOZWIPSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- QEVGZEDELICMKH-UHFFFAOYSA-N Diglycolic acid Chemical compound OC(=O)COCC(O)=O QEVGZEDELICMKH-UHFFFAOYSA-N 0.000 description 1
- 239000004214 Fast Green FCF Substances 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000000576 Iodoproteins Human genes 0.000 description 1
- 108010041739 Iodoproteins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical group [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- CBMCZKMIOZYAHS-NSCUHMNNSA-N [(e)-prop-1-enyl]boronic acid Chemical compound C\C=C\B(O)O CBMCZKMIOZYAHS-NSCUHMNNSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DGOBMKYRQHEFGQ-UHFFFAOYSA-L acid green 5 Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 DGOBMKYRQHEFGQ-UHFFFAOYSA-L 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000001814 protein method Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
- G01N33/6839—Total protein determination, e.g. albumin in urine involving dyes, e.g. Coomassie blue, bromcresol green
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/548,437 US5593895A (en) | 1995-04-27 | 1995-10-26 | Method for the detection of protein in urine |
| US8/548,437 | 1995-10-26 | ||
| US08/548,437 | 1995-10-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR970022313A KR970022313A (ko) | 1997-05-28 |
| KR100460361B1 true KR100460361B1 (ko) | 2005-01-24 |
Family
ID=24188841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019960048173A Expired - Lifetime KR100460361B1 (ko) | 1995-10-26 | 1996-10-25 | 요중단백질검출용시험스트립및요중단백질시험 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5593895A (enExample) |
| EP (1) | EP0770873B1 (enExample) |
| JP (1) | JP3621209B2 (enExample) |
| KR (1) | KR100460361B1 (enExample) |
| CA (1) | CA2188612C (enExample) |
| DE (1) | DE69625024T2 (enExample) |
| TW (1) | TW382063B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5753455A (en) * | 1996-09-03 | 1998-05-19 | Bayer Corporation | Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid |
| JP3308173B2 (ja) * | 1996-11-07 | 2002-07-29 | 松下電器産業株式会社 | 尿検査方法およびそれに用いる尿検査装置 |
| US5856199A (en) * | 1997-03-05 | 1999-01-05 | Environmental Test Systems, Inc. | Colorimetric dry reagent test device and method for the determination of analytes in solutions containing interfering colored substances |
| DE19858949B4 (de) * | 1998-12-10 | 2004-09-23 | Levin, Felix, Dr. | Testkit zur Bestimmung von Eiweiß in biologischen Flüssigkeiten, insbesondere im Urin |
| WO2003001213A2 (en) * | 2001-06-25 | 2003-01-03 | Bayer Healthcare Llc | Total protein detection methods and devices at low ph |
| US20070134740A1 (en) * | 2005-12-12 | 2007-06-14 | David Brusilovsky | Compositions and articles for detection of analytes exceeding a pre-set threshold |
| US7563621B2 (en) * | 2002-03-05 | 2009-07-21 | Siemens Healhcare Diagnostics Inc | Absorbing organic reagents into diagnostic test devices by formation of amine salt complexes |
| EP1536233B1 (en) * | 2002-08-09 | 2010-10-13 | ARKRAY, Inc. | Test piece for protein assay |
| CN106940376B (zh) | 2011-08-19 | 2020-05-05 | 艾昆西恩斯公司 | 蛋白质检测 |
| JP5542888B2 (ja) * | 2011-10-17 | 2014-07-09 | アークレイ株式会社 | 蛋白質濃度評価方法、分析用具、及び分析装置 |
| CN105277656B (zh) | 2014-07-01 | 2018-12-25 | 科蒙森斯公司 | 用于鉴定羊水的诊断组合物 |
| CN114034693A (zh) * | 2021-11-04 | 2022-02-11 | 广州达安基因股份有限公司 | 一种检测尿肌酐尿微量白蛋白半定量的联检试纸、其制备方法及用途 |
| WO2025070455A1 (ja) * | 2023-09-26 | 2025-04-03 | 富士フイルム株式会社 | タンパク質測定用試験片及びタンパク質の測定方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05172821A (ja) * | 1991-12-20 | 1993-07-13 | Eiken Chem Co Ltd | 尿中蛋白質検出方法及び試験片 |
| US5279790A (en) * | 1991-06-06 | 1994-01-18 | Miles Inc. | Merocyanine and nitro or nitroso substituted polyhalogenated phenolsulfonephthaleins as protein indicators in biological samples |
| US5385847A (en) * | 1993-12-02 | 1995-01-31 | Miles Inc. | Method for the determination of urinary protein and creatinine |
| US5908787A (en) * | 1997-09-23 | 1999-06-01 | Bayer Corporation | Total protein detection method |
| KR20000042168A (ko) * | 1998-12-24 | 2000-07-15 | 박호군 | 간질환관련 표식물질의 검출용 스트립 및 이를 이용한간질환 진단방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3485587A (en) * | 1956-02-29 | 1969-12-23 | Miles Lab | Protein indicator |
| DE2510633C3 (de) * | 1975-03-12 | 1978-07-13 | Boehringer Mannheim Gmbh, 6800 Mannheim | Diagnostisches Mittel zum Nachweis von Eiweiß in Körperflüssigkeiten und dafür geeignete Indikatorfarbstoffe |
| US4333733A (en) * | 1980-07-17 | 1982-06-08 | Eastman Kodak Company | Continuous release of reagent in an analytical element to reduce assay interference |
| US4960710A (en) * | 1988-06-06 | 1990-10-02 | Miles Inc. | Device and method of assaying for trace mounts of proteins |
| US5055407A (en) * | 1988-07-05 | 1991-10-08 | Miles, Inc. | Composition and method of assaying aqueous liquids for specific gravity |
| JP3045761B2 (ja) * | 1990-11-14 | 2000-05-29 | 株式会社京都第一科学 | 補正用紙片を有する呈色試験紙 |
| US5326707A (en) * | 1991-11-29 | 1994-07-05 | Miles Inc. | Composition and device for urinary protein assay and method of using the same |
| US5424215A (en) * | 1994-02-07 | 1995-06-13 | Miles Inc. | Assay for the determination of protein in a biological sample |
-
1995
- 1995-10-26 US US08/548,437 patent/US5593895A/en not_active Expired - Lifetime
-
1996
- 1996-06-05 TW TW085106727A patent/TW382063B/zh not_active IP Right Cessation
- 1996-09-17 EP EP96114867A patent/EP0770873B1/en not_active Expired - Lifetime
- 1996-09-17 DE DE69625024T patent/DE69625024T2/de not_active Expired - Lifetime
- 1996-10-22 JP JP27953696A patent/JP3621209B2/ja not_active Expired - Lifetime
- 1996-10-23 CA CA002188612A patent/CA2188612C/en not_active Expired - Fee Related
- 1996-10-25 KR KR1019960048173A patent/KR100460361B1/ko not_active Expired - Lifetime
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5279790A (en) * | 1991-06-06 | 1994-01-18 | Miles Inc. | Merocyanine and nitro or nitroso substituted polyhalogenated phenolsulfonephthaleins as protein indicators in biological samples |
| JPH05172821A (ja) * | 1991-12-20 | 1993-07-13 | Eiken Chem Co Ltd | 尿中蛋白質検出方法及び試験片 |
| US5385847A (en) * | 1993-12-02 | 1995-01-31 | Miles Inc. | Method for the determination of urinary protein and creatinine |
| US5908787A (en) * | 1997-09-23 | 1999-06-01 | Bayer Corporation | Total protein detection method |
| KR20000042168A (ko) * | 1998-12-24 | 2000-07-15 | 박호군 | 간질환관련 표식물질의 검출용 스트립 및 이를 이용한간질환 진단방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3621209B2 (ja) | 2005-02-16 |
| US5593895A (en) | 1997-01-14 |
| TW382063B (en) | 2000-02-11 |
| JPH09145711A (ja) | 1997-06-06 |
| CA2188612C (en) | 2003-10-07 |
| EP0770873A2 (en) | 1997-05-02 |
| EP0770873A3 (en) | 1998-08-12 |
| DE69625024D1 (de) | 2003-01-09 |
| EP0770873B1 (en) | 2002-11-27 |
| KR970022313A (ko) | 1997-05-28 |
| DE69625024T2 (de) | 2003-04-17 |
| CA2188612A1 (en) | 1997-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5302531A (en) | Composition for the semiquantitative determination of specific gravity of a test sample | |
| JP3097869B2 (ja) | イオン成分センサー並びに該イオンセンサーの製造方法及び使用方法 | |
| KR100460361B1 (ko) | 요중단백질검출용시험스트립및요중단백질시험 | |
| JP2519102B2 (ja) | 水性液を比重に関して試験するための組成物及び方法 | |
| ES2707743T3 (es) | Método para la detección de tiras para prueba de orina con compromiso por humedad | |
| AU606283B2 (en) | Composition and method of assaying for trace amounts of proteins | |
| US5403744A (en) | Method, composition and device for measuring the ionic strength or specific gravity of a test sample | |
| JP3219874B2 (ja) | 尿タンパク質検定のための改良された組成物および試験具ならびにそれを用いる方法 | |
| JP3061447B2 (ja) | 総蛋白を分析するための試験用パッドの製造方法、試験具、それを用いる測定方法及び試験具の製造方法 | |
| US20160338883A1 (en) | Indicator panels for incontinence products | |
| PL106419B1 (pl) | Srodek do oznaczania kwasu moczowego | |
| US5320969A (en) | Method, composition and device for the semiquantitative determination of specific gravity of a test sample | |
| CA2214400C (en) | Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid | |
| JPH05172822A (ja) | 水性液体のイオン強度及び／又は比重量の測定用試薬及び測定方法 | |
| JP3516012B2 (ja) | 微量の蛋白質を測定するための組成物 | |
| EP0793099A1 (en) | Improved method for the detection of protein | |
| US4594225A (en) | Elements for analysis of calcium | |
| JP3955911B2 (ja) | 尿中のアルブミン測定方法、尿中のアルブミン測定用指示薬、および尿中のアルブミン測定用試験片 | |
| US20210177351A1 (en) | Indicator panels for incontinence products | |
| KR100503562B1 (ko) | 단백질측정용건식분석요소 | |
| JPH11337547A (ja) | タンパク質測定用乾式分析要素およびタンパク質測定法 | |
| JP2522970B2 (ja) | 体液中のクレアチニン定量用試験片及びその製法 | |
| US6638480B2 (en) | High sensitivity test system for the colorimetric determination of specific gravity or total dissolved solids in aqueous samples | |
| JPH03100462A (ja) | 溶液のイオン濃度、比重または浸透圧の測定器具 | |
| PL101392B1 (pl) | Srodek do wykrywania kwasu moczowego w plynach |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19961025 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20010813 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19961025 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20040226 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20040924 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20041129 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20041130 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20071026 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20081027 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20091008 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20101012 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20111013 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20121017 Start annual number: 9 End annual number: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20131015 Year of fee payment: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20131015 Start annual number: 10 End annual number: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20141021 Year of fee payment: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20141021 Start annual number: 11 End annual number: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20151020 Year of fee payment: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20151020 Start annual number: 12 End annual number: 12 |
|
| EXPY | Expiration of term | ||
| PC1801 | Expiration of term |